AACR 2024 | Enhanced NK-cells in stage 4 sarcoma treatment

Vaishali Kumar, MBBS, Sarcoma Oncology Research Center, Santa Monica, CA, discusses the use of enhanced NK-cells to treat stage 4 sarcoma. Phase I clinical trials and compassionate uses of autologous enhanced NK-cells show promising response rates and prolonged survival. This interview took place at American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.